COVID-19 Could Lead To Rise In Deaths Due To Drug Overdose

by StartupWorld Staff         

The Centers for Disease Control and Prevention (CDC) preliminary data show that deaths will rise cause overdosage of the drug in the US. The CDC has also reported that there were more than 70,000 deaths in 2019. According to the Drug Policy Alliance, the comparative data shows a 4.9% hike in the number, and this year it could continue to rise again.

While the increase in overdose deaths in the U.S. in 2019 is devastating, it is not at all surprising, and there is reason to believe that these deaths will continue to climb in 2020 as a result of the COVID-19 pandemic, which has increased isolation, disrupted the drug supply and reduced access to harm reduction and treatment supports.

The Drug Policy Alliance department of research and academic engagement Deputy Director Sheila Vakharia said that death due to overdosage was first seen in 1990, and a small decline in the deaths due to the same reason was seen in 2018. All the lawmakers celebrated the drop in the number in deaths, including President Donald Trump. However, Sheila Vakharia also mentioned that this was their mistake, as the detailed study of the data shown that the US had achieved a hollow victory.

COVID-19 Could Lead To Rise In Deaths Due To Drug Overdose

In 2019, the lawmakers tried to do a victory lap over a 4.5% less in overdose deaths compared to 2018. They also warned that the data did not subject to the fact that there were several states where the overdoses have increased. Even the data did not clarify the racial and other demographic discrepancies or the drastic increase in stimulant overdoses in the past few years, she said. This remains still true today.

Since 1990, over 700,000 people have died due to overdosage of drugs. The hike in the number is mostly considered the opioid epidemic, and the data reveals in 2019 have shown that not much has changed- 70,980 people died from drug overdoses last year, including 50,042 deaths due to opioids.

Another recent CDC report suggests that in 2019, 6.6% of women had consumed opioid pain killers while pregnant. The author reported that 1 in 5 women admitted that they had misused opioids. They also suggested advance screening for opioid misuse and treatment of opioid use disorder in pregnant patients.

Sheila Vakharia added that it is essential right now to harm reduction strategy around the US. The novel endemic has disturbed many ways of life, with a disorientation effect on communities hit hardest by increase drug overdose deaths. According to Sheila Vakharia, all the reports have revealed the health inequities of the body.

Now it is essential more than ever that they work on double-down the overdose prevention approaches, as guided by DPA’s COVID-19 policy recommendations, Sheila Vakharia added. It also includes the improved substance used in disorder treatment. It raises access to harm reduction services like keeping loosened regulations for buprenorphine and allocating federal funding towards syringe exchange and naloxone methadone in place, allowing the overdose prevention sites to open the access legally.


4.1/5

145 Reviews

Your rate 3 stars is recorded

About Author

StartupWorld Staff

StartupWorld is the destination to learn about new and upcoming startups making waves on the web. Being an entrepreneur is as much hard work as it is fun. No one knows it better than you do. Share your story, send it in and let us showcase it to the world.

Comments ()

Leave a Comment